- COPD now No. 3 leading cause of death among Americans
- Adherence among chronic disease patients can lead to big savings
- Pfizer forms licensing agreement with Seattle Genetics
- Walgreens puts its money where its mouth is with World AIDS Day campaign
- Walgreens launches high-impact push in support of World AIDS Day campaign
RIDGEFIELD, Conn. — Two organizations focused on chronic obstructive pulmonary disorder have joined Drive4COPD, an organization founded by drug maker Boehringer Ingelheim that seeks to raise awareness of the disease.
Drive4COPD announced that the U.S. COPD Coalition and the COPD Alliance had joined the campaign, which now includes 40 associations and companies. The U.S. COPD Coalition adds another 38 organizations.
“It is incredible what Drive4COPD has been able to accomplish in its first year,” U.S. COPD Coalition vice chair John Walsh said. “By working together as a unified COPD community with a singular voice, we can effectively mobilize shared resources to find those who may be at risk for this disease and don’t know it.”